Monday, 31 August 2026European Markets

SALMAR And SIPEF Have A High Dividend Yield And Return On Equity In The Farm Products Industry.

Loading stream...

(VIANEWS) - SALMAR (SALM.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Farm Products industry.

Financial Asset Price Forward Dividend Yield Return on Equity
SALMAR (SALM.OL) kr690.00 5.36% 11.63%
SIPEF (SIP.BR) €56.80 3.56% 8.78%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. SALMAR (SALM.OL)

5.36% Forward Dividend Yield and 11.63% Return On Equity

SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, North America, Europe, and internationally. The company operates through Fish Farming Central Norway, Fish Farming Northern Norway, Icelandic Salmon, Sales & Industry, and SalMar Aker Ocean segments. It is involved in the broodstock, harvesting, processing, and smolt production activities. In addition, the company offers fish fillets and related products. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.

Earnings Per Share

As for profitability, SALMAR has a trailing twelve months EPS of kr19.37.

PE Ratio

SALMAR has a trailing twelve months price to earnings ratio of 35.62. Meaning, the purchaser of the share is investing kr35.62 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.63%.

Volume

Today's last reported volume for SALMAR is 37667 which is 76.08% below its average volume of 157486.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 7, 2024, the estimated forward annual dividend rate is 35 and the estimated forward annual dividend yield is 5.36%.

More news about SALMAR.

2. SIPEF (SIP.BR)

3.56% Forward Dividend Yield and 8.78% Return On Equity

Sipef NV operates as an agro-industrial company. The company operates through Palm, Rubber, Tea, and Bananas and horticulture segments. It also offers crude palm oil, palm kernels, and palm kernel oil ; ribbed smoked sheets, and scraps and lumps; cut, tear, and curl tea; flowers, foliage, and bananas. The company operates in Papua New Guinea, Ivory Coast, Singapore, Europe, Indonesia, and internationally. Sipef NV was incorporated in 1919 and is headquartered in Schoten, Belgium.

Earnings Per Share

As for profitability, SIPEF has a trailing twelve months EPS of €6.76.

PE Ratio

SIPEF has a trailing twelve months price to earnings ratio of 8.4. Meaning, the purchaser of the share is investing €8.4 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.78%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SIPEF's stock is considered to be overbought (>=80).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 14, 2024, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 3.56%.

More news about SIPEF.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com